Charles River Laboratories (CRL)
EBITDA Margin
15.02%
Quarterly · Period ending:
CRL EBITDA Margin
Latest reported15.02%period ending
Latest reported15.02%period ending
CRL Quarterly EBITDA Margin (32.96% → 15.02%)
Quarterly ebitda margin
High-resolution chart · PNG
CRL ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 15.0188% | |
| 6.4219% | |
| -19.3162% | |
| 19.6812% | |
| 21.4015% | |
| 18.719% | |
| -8.6233% | |
| 20.7695% | |
| 23.2434% | |
| 21.6862% | |
| 31.8472% | |
| 21.9638% | |
| 22.773% | |
| 23.5571% | |
| 32.4815% | |
| 21.1379% | |
| 23.0428% | |
| 21.3998% | |
| 26.7863% | |
| 23.2618% | |
| 23.1565% | |
| 19.1045% | |
| 33.6856% | |
| 28.7533% | |
| 23.5153% | |
| 18.0729% | |
| 26.2987% | |
| 19.566% | |
| 19.6139% | |
| 20.1193% | |
| 22.1718% | |
| 22.9105% | |
| 22.6084% | |
| 21.7505% | |
| 23.0442% | |
| 24.572% | |
| 24.7518% | |
| 26.3461% | |
| 22.8748% | |
| 22.1843% | |
| 22.0368% | |
| 22.6608% | |
| 22.4287% | |
| 23.1271% | |
| 25.8713% | |
| 17.8968% | |
| 20.9302% | |
| 22.2739% | |
| 22.9252% | |
| 21.992% | |
| 19.0964% | |
| 24.6333% | |
| 22.1214% | |
| 21.9539% | |
| 19.6944% | |
| 20.6196% | |
| 23.9334% | |
| 22.2333% | |
| 21.8592% | |
| 20.7699% | |
| 26.115% | |
| 22.37% | |
| -126.2029% | |
| 10.3404% | |
| 17.9501% | |
| 18.0474% | |
| 18.8658% | |
| 23.8163% | |
| 24.512% | |
| 20.6384% | |
| -200.7218% | |
| 26.8971% | |
| 26.7322% | |
| 25.9961% | |
| 23.8916% | |
| 27.4611% | |
| 25.5638% | |
| 25.8638% | |
| 24.9108% | |
| 27.7337% | |
| 25.6807% | |
| -22.8827% | |
| 21.7142% | |
| 29.975% | |
| 24.0141% | |
| 26.1093% | |
| 23.7767% | |
| 29.4599% | |
| 29.0477% | |
| 27.6285% | |
| 28.3786% | |
| 27.7167% | |
| 27.5051% | |
| 26.9699% | |
| 26.4831% | |
| 27.8416% | |
| 26.7844% | |
| 25.5702% | |
| 24.32% | |
| 25.4615% |